Actionnariat et activité des initiés pour Dyadic International, Inc. (DYAI): transactions des initiés, déclarations de trading du Sénat et de la Chambre américaine et actions en circulation. Suivez comment dirigeants et politiciens négocient le titre.
Prix
| Prix | $0.40 |
| Capitalisation | $15M |
| Bourse | NASDAQ |
| Pays | US |
Transactions d'Initiés Récentes
| Date | Initié | Type | Actions | Valeur |
|---|---|---|---|---|
| 2026-07-22 | Francisco Trust under agreement dated February 28, 1996 | S-Sale | 38,016 | $50K |
| 2026-07-23 | Francisco Trust under agreement dated February 28, 1996 | S-Sale | 54,760 | $71K |
| 2026-07-24 | Francisco Trust under agreement dated February 28, 1996 | S-Sale | 2,616 | $3K |
| 2024-06-06 | Francisco Trust under agreement dated February 28, 1996 | S-Sale | 26,340 | $64K |
| 2024-12-20 | Francisco Trust under agreement dated February 28, 1996 | S-Sale | 25,281 | $47K |
| 2024-12-23 | Francisco Trust under agreement dated February 28, 1996 | S-Sale | 41,143 | $76K |
| 2024-12-24 | Francisco Trust under agreement dated February 28, 1996 | S-Sale | 5,100 | $9K |
| 2024-12-30 | Francisco Trust under agreement dated February 28, 1996 | S-Sale | 40,000 | $79K |
| 2025-01-06 | Francisco Trust under agreement dated February 28, 1996 | S-Sale | 20,000 | $38K |
| 2025-01-07 | Francisco Trust under agreement dated February 28, 1996 | S-Sale | 15,000 | $30K |
Bilan (10 ans)
| Année | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Trésorerie | $6.9M | $5.8M | $2.4M | $4.8M | $20.6M | $15.7M | $5.8M | $6.5M | $6.5M | $4.6M |
| Placements à Court Terme | $42.1M | $41.9M | $38.8M | $29.4M | $8.5M | $4.5M | $6.8M | $748290 | $2.8M | $2.7M |
| Créances | $1.1M | $760870 | $1.1M | $1.1M | $294199 | $372206 | $330001 | $466159 | $237027 | $1.1M |
| Stocks | $7.4M | $1.0M | $253446 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Actifs Courants | $57.6M | $49.6M | $42.7M | $35.6M | $29.8M | $21.0M | $13.4M | $8.1M | $9.8M | $9.9M |
| Immobilisations Corporelles | 0 | 0 | 0 | 0 | 0 | 0 | 0 | $141439 | $92211 | $38535 |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Actifs Incorporels | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Actifs Totaux | $58.7M | $50.7M | $43.3M | $37.5M | $30.1M | $21.3M | $13.7M | $8.2M | $9.9M | $9.9M |
| Dettes Fournisseurs | $279057 | $520261 | $309060 | $792995 | $1.0M | $1.5M | $1.3M | $656445 | $482320 | $852024 |
| Dette à Court Terme | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Passifs Courants | $1.0M | $768895 | $849638 | $1.6M | $1.6M | $2.6M | $2.4M | $2.3M | $2.4M | $3.7M |
| Dette à Long Terme | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | $5.0M | $5.0M |
| Passifs Totaux | $1.0M | $768895 | $849638 | $1.6M | $1.6M | $2.9M | $2.6M | $2.3M | $7.5M | $8.7M |
| Réserves | -$25.2M | -$27.4M | -$33.0M | -$41.4M | -$50.7M | -$63.7M | -$73.5M | -$80.3M | -$86.1M | -$93.5M |
| Capitaux Propres | $57.7M | $50.0M | $42.5M | $35.9M | $28.4M | $18.4M | $11.1M | $5.9M | $2.5M | $1.2M |
| Dette Totale | 0 | 0 | 0 | 0 | 0 | 0 | 0 | $136929 | $5.1M | $5.1M |
| Dette Nette | -$48.9M | -$47.7M | -$41.2M | -$34.2M | -$29.1M | -$20.3M | -$12.6M | -$7.1M | -$4.2M | -$2.3M |
| Fonds de Roulement | $56.6M | $48.8M | $41.9M | $34.1M | $28.2M | $18.5M | $11.0M | $5.8M | $7.4M | $6.2M |
Santé financière
| Dette / Capitaux propres | -2.11 |
| Ratio de liquidité | 1.65 |
Rentabilité
| Rentabilité des capitaux propres | -2918.10% |
| Rentabilité du capital investi | -278.95% |
| Rentabilité des actifs | -116.60% |
| Marge brute | 30.44% |
| Marge opérationnelle | -213.59% |
| Marge nette | -219.50% |
Entreprises liées: ANVS · ATHE · BCAB · CELU · ELUT · MAIA · PYPD
Explorer le secteur: Healthcare · Biotechnology
Plus de sections de DYAI: Vue d'ensemble · Financiers · Valorisation · Statistiques · Estimations · Technique · Actualités · Événements
Découvrir plus: Radar — signaux d'actions sous-évaluées · Académie d'Investissement — apprenez à analyser les actions